Cibus (CBUS) Short Interest


CBUS Cibus Inc CBUS
53 GF Score
Price $1.36
GF Value $2.04
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cibus Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CBUS vs OTLK, INO, RANI: Short Interest Comparison

For the Biotechnology subindustry, Cibus's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cibus Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cibus's Short Interest distribution charts can be found below:

* The bar in red indicates where Cibus's Short Interest falls into.


CBUS
53GF Score
Cibus Inc CBUS
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cibus (CBUS) Overvalued in 2026?

Based on GuruFocus' analysis, Cibus stock appears to be undervalued. The current stock price of $1.36 is trading 33.3% below its estimated GF Value™ of $2.04. GuruFocus considers Cibus to be Possible Value Trap.

Key valuation signals for CBUS:

  • Short Interest:
  • GF Value™: $2.04 vs. price of $1.36 (33.3% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the CBUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cibus Business Description

Address 6455 Nancy Ridge Drive, San Diego, CA, USA, 92121
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
53GF Score

Get the complete analysis for CBUS

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.36
Price
$2.04
GF Value